Download PDF
1 / Pages

Other users also viewed these articles

Prolonged-release pirfenidone decreases hepatic miRNAs expression in a NAFLD/NASH experimental model R. Escutia-Gutiérrez; J.S. Rodríguez-Sanabria; C.A. Monraz-Méndez; A. Santos-García; J. Armendáriz-Borunda; A. Sandoval-Rodríguez;
Ann Hepatol. 2020;19 Supl 1:5-6
Prolonged-release pirfenidone prevents myocardial fibrosis in a mouse nonalcoholic steatohepatitis model J. Gutiérrez-Cuevas; A. Sandoval-Rodríguez; C. Monroy-Ramírez; A. Santos-García; J. Armendáriz-Borunda;
Ann Hepatol. 2020;19 Supl 1:9
Analysis of the molecular interaction of pirfenidone with PPAR-gamma and effects on the beta-catenine pathway in HEPG2 line H.C. Monroy-Ramírez; J.A. Silva-Gómez; M. Galicia-Moreno; A. Santos-García; J. Armendáriz-Borunda;
Ann Hepatol. 2020;19 Supl 1:9